W-54011
用途生物活性靶点体外研究体内研究 用途与合成方法 MSDS W-54011价格(试剂级) 上下游产品信息
| 中文名称 | W-54011 |
|---|---|
| 中文同义词 | 化合物 T17250;N-(4-(二甲氨基)苄基)-N-(4-异丙基苯基)-7-甲氧基-1,2,3,4-四氢萘-1-甲酰胺盐酸盐;化合物W-54011;W 54011,C5A受体拮抗剂 |
| 英文名称 | N-[[4-(DIMETHYLAMINO)PHENYL]METHYL]-1,2,3,4-TETRAHYDRO-7-METHOXY-N-[4-(1-METHYLETHYL)PHENYL]-1-NAPHTHALENECARBOXAMIDE HYDROCHLORIDE |
| 英文同义词 | N-[[4-(DIMETHYLAMINO)PHENYL]METHYL]-1,2,3,4-TETRAHYDRO-7-METHOXY-N-[4-(1-METHYLETHYL)PHENYL]-1-NAPHTHALENECARBOXAMIDE HYDROCHLORIDE;N-{[4-(diMethylaMino)phenyl]Methyl}-7-Methoxy-N-[4-(propan-2-yl)phenyl]-1,2,3,4-tetrahydronaphthalene-1-carboxaMide hydrochloride;W-54011;C5a Receptor Antagonist, W-54011;CS-2062;chemotaxis,inhibit,orally,W-54011,mobilization,anaphylatoxin,ROS,Reactive Oxygen Species,Ca2+,C5a,neutrophils,Inhibitor,Complement System,W54011,inflammatory,W 54011;N-[[4-(DIMETHYLAMINO)PHENYL]METHYL]-1,2,3,4-TETRAHYDRO-7-METHOXY-N-[4-(1-METHYLETHYL)PHENYL]-1-NAPHTHALENECARBOXAMIDE HYDROCHLORIDE |
| CAS号 | 405098-33-1 |
| 分子式 | C30H37ClN2O2 |
| 分子量 | 493.08 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | 405098-33-1.mol |
| 结构式 | ![]() |
W-54011 性质
| 储存条件 | Store at -20°C |
|---|---|
| 溶解度 | DMF:30mg/mL;二甲基亚砜:30mg/mL;乙醇:3mg/mL |
| 形态 | 白色粉末状固体。 |
| 颜色 | 白色至浅黄色 |
| 稳定性 | 吸湿性 |
W-54011 用途与合成方法
用途
W-54011是一种有效的口服非肽C5a受体拮抗剂。
生物活性
W-54011 是一种有效的,具有口服活性的非肽 C5a 受体拮抗剂。W-54011 抑制 125I 标记的 C5a 与人嗜中性白细胞的结合,Ki 值为 2.2 nM。W-54011 还抑制 C5a 诱导的人嗜中性粒细胞的细胞内 Ca2+ 动员,趋化性和 ROS 的生成,IC50 值分别为 3.1 nM、2.7 nM 和1.6 nM。
靶点
Ki: 2.2 nM (C5a)sup>[1]
IC50: 3.1 nM (Ca
2+
mobilization,), 2.7 nM (Chemotaxis), and 1.6 nM (ROS)
体外研究
In C5a-induced intracellular Ca 2+ mobilization assay with human neutrophils, W-54011 does not show agonistic activity at up to 10 μM and shifts rightward the concentration-response curves to C5a without depressing the maximal responses, indicating that W-54011 is a full antagonist. At concentrations up to 10 μM, W-54011 does not affect Ca2+ mobilization stimulated with sub-maximally effective concentrations of fMLP (1 nM), plateletactivating factor (0.3 nM), and IL-8 (0.1 nM). This result demonstrates that W-54011 is highly specific for C5a receptor.
体内研究
W-54011 (3-30 mg/kg; oral administration; for 4 hours; male mongolian gerbils) treatment inhibited C5a-induced neutropenia in a dose-dependent manner in gerbils.
The species selectivity of W-54011 is examined in rhC5a-induced intracellular Ca
2+
mobilization of neutrophils in various species. The W-54011 is able to inhibit the response in cynomolgus monkeys and gerbils with IC
50
values of 1.7 nM and 3.2 nM, respectively, but not in mice, rats, guinea pigs, rabbits, and dogs.
| Animal Model: | Male mongolian gerbils (6-12 weeks) injected with rhC5a |
| Dosage: | 3 mg/kg, 10 mg/kg, 30 mg/kg |
| Administration: | Oral administration; for 4 hours |
| Result: | Inhibited C5a-induced neutropenia in a dose-dependent manner. |
安全信息
MSDS信息
W-54011 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2024/08/19 | HY-16992A | W-54011 W-54011 | 405098-33-1 | 1mg | 690元 |
| 2024/08/19 | HY-16992A | W-54011 W-54011 | 405098-33-1 | 5mg | 1400元 |



VIP会员
粤公网安备44196802000105号